Thank you, Claus, and good afternoon, everyone. Before moving into the individual segments and our quarter-over-quarter discussion, let me briefly put the fourth quarter into perspective. Group EBITDA increased to EUR 88 million in the fourth quarter compared with a loss of EUR 8 million in the prior year quarter. As shown on this slide, the Bioethanol/Biomethane segment was the main driver behind this improvement, increasing EBITDA from a loss of EUR 26 million in Q4 '24, '25 to a profit of EUR 55.0 million in Q4 '25, '26. Now compared with the prior year, bioethanol market spreads improved in both Europe and North America. The greenhouse gas quota market also recovered from market distortions in the previous year. And in addition, our North American operations benefited from higher utilization rates. It should be noted that the year-on-year comparison was also supported by the reversal of the impairment on greenhouse gas quota inventories recorded in the prior year as well as by the absence of several negative effects that weighted on Q4 '24, '25. Biodiesel also contributed positively. However, the Bioethanol/Biomethane segment was clearly the main driver of the improvement at group level. With that, let me now turn to the quarter-over-quarter performance of the individual segments, starting with biodiesel. Production volumes increased from 145,000 tonnes in the third quarter to 172,000 tonnes in the fourth quarter. In Europe, production reached another record level, confirming the strong operational performance of the segment. Production in Canada also increased compared with the previous quarter following the planned winter shutdown. Our revenues rose significantly to EUR 280 million from EUR 202 million (sic) [ EUR 202.7 million ] in the third quarter. This was driven by higher sales volumes and higher biodiesel selling prices. In Europe, demand benefited from the implementation of the RED III, which increased demand for physical biodiesel. At the same time, low water levels on the Rhine created logistical challenges for some market participants. We, as Verbio, on the other hand, were able to continue serving our customers through our established rail and truck deliveries. Despite weaker benchmark spreads in Europe, which we will look at in a minute, our gross margin improved significantly compared to the previous quarter. Higher biodiesel prices supported profitability, thanks to our beneficial feedstock sourcing. In North America, higher utilization rates, increased sales volumes, and improved efficiency provided additional support. As a result, EBITDA increased to EUR 32 million (sic) [ EUR 32.8 million ] from EUR 18 million (sic) [ EUR 18.5 million ] in the previous quarter. Now for some market context, let's now take a look at the reference charts. These charts show the development of the biodiesel spreads, which are defined as the difference between biodiesel prices and rapeseed oil prices. As always, they do not reflect our specific sourcing strategy, but provide a useful indication of broader market developments. Looking specifically at the fourth quarter, benchmark market spreads deteriorated significantly. And as you can see from the dark green line on the left of the chart, turned slightly negative towards the end of the financial year. The chart on the right helps explain this development. Both biodiesel and rapeseed oil prices increased during the quarter. However, rapeseed oil prices rose much more strongly than biodiesel prices, putting significant pressure on the benchmark market spreads. The increase in rapeseed oil prices was primarily driven by stronger vegetable oil markets and improved market demand expectations for renewable fuels. A key driver of these improvement expectations was the EPA's final Renewable Fuel Standard decision in March this year, which provided greater regulatory certainty and supported market confidence in future renewable fuel demand. Biodiesel prices also moved higher, supported by the ongoing recovery of greenhouse gas quota markets and stronger demand following the implementation of RED III. However, while RED III is improving demand fundamentals, additional biodiesel volumes remain constrained by the blending wall. In addition, elevated diesel prices associated with the conflict with Iran weighed on overall diesel demand, further limiting the ability of biodiesel prices to keep pace with rising feedstock costs. Despite the weaker benchmark environment, we achieved a significantly stronger result than implied by the reference market spreads. This was supported by our favorable feedstock sourcing, higher greenhouse gas quota prices, and additional value creation through our integrated biorefinery model. Now let's move on to the Bioethanol/Biomethane segment. Biomethane production reached another record level of more than 370 gigawatt-hours, supported by the continued ramp-up of our Nevada facility. Bioethanol production also increased. The main driver was higher output in North America, while production in Europe recovered following the temporary biological disruptions in the fermentation process that affected the previous quarter. Our revenue increased to EUR 243 million (sic) [ EUR 243.5 million ] from EUR 236 million in the third quarter. Higher bioethanol prices as well as increased sales volumes supported revenue growth. Now while greenhouse gas quota prices also increased further, revenues from the greenhouse gas quota business in Europe were below the level of the seasonally strong third quarter. Gross margin improved compared with the previous quarter. Large market spreads... [Technical Difficulty]